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Toward a Better Understanding of...
Using Cave Bacteria to Inhibit 
Pseudogymnoascus destructans, 
the White Nose Pathogen
Austin Chan
Mentor: Joshua Blodgett
Pseudogymnoascus destructans, the causative fungus of White Nose Syndrome (WNS), 
has rapidly spread across the world endangering many species of bats through 
accelerating their use of stored fuels during hibernation. Bats diagnosed with WNS have 
faced 100% mortality in caves, causing concern among scientists. In hopes of controlling 
this fungus, we are screening cave bacteria for antifungal compounds inhibitory to P. 
destructans. Streptomyces, a widely distributed genus of filamentous bacteria, have a long 
history of producing antibiotics. They have been known to synthesize a wide variety 
of our current day antibiotics (amphotericin, neomycin, etc.) and serve as a great 
discovery platform for new antibiotics. With this reasoning, we performed enrichments 
to isolate cave Streptomyces, amassing a library of over 500 individual strains. To screen 
for antibiotic activity, we tested our library against the yeast Saccharomyces cerevisiae and 
P. destructans. Strains giving the strongest inhibition were subjected to further analysis 
by mass spectrometry, chromatography and additional bioassays. Additionally, we are 
collaborating with the Doering Lab (Washington University) who has screened our 
antibiotic producing strains against Cryptococcus neoformans, a facultative intracellular 
pathogen that causes severe lung infections in humans. Within our library, we have 
found 58 Streptomyces strains that have produced antibiotic activity. Our strains have 
exhibited a wide range of activities from producing broad antibiotic activity to strains 
that have been more selective against P. destructans. Through our data, we are working 
to identify specific antibiotics compounds and find strain candidates that will control 
the spread of WNS.
